Thu, May 16, 2024
Wed, May 15, 2024
Tue, May 14, 2024

Asthika Goonewardene Maintained (ALLO) at Strong Buy and Held Target at $17 on, May 15th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-17-on-may-15th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Asthika Goonewardene of Truist Securities, Maintained "Allogene Therapeutics, Inc." (ALLO) at Strong Buy and Held Target at $17 on, May 15th, 2024.

Asthika has made no other calls on ALLO in the last 4 months.



There are 4 other peers that have a rating on ALLO. Out of the 4 peers that are also analyzing ALLO, 1 agrees with Asthika's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Benjamin Burnett of "Stifel" Maintained at Hold with Increased Target to $4.6 on, Tuesday, May 14th, 2024


These are the ratings of the 3 analyists that currently disagree with Asthika


  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $10 on, Tuesday, March 19th, 2024
  • Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $10 on, Friday, March 15th, 2024
  • Brian Cheng of "JP Morgan" Maintained at Buy with Decreased Target to $8 on, Tuesday, February 27th, 2024

Publication Contributing Sources